Comparison of Outcomes Between Intraosseous Femoral and Tibial Injection in Simultaneous Bilateral Total Knee Arthroplasty Patients - Trial NCT06243575
Access comprehensive clinical trial information for NCT06243575 through Pure Global AI's free database. This phase not specified trial is sponsored by Rajavithi Hospital and is currently Recruiting. The study focuses on Pain, Postoperative. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Rajavithi Hospital
Timeline & Enrollment
N/A
Feb 01, 2024
Apr 30, 2024
Primary Outcome
Pain score (Visual analog scale)
Summary
In patients with osteoarthritis of the knee whose pain cannot be relieved by conservative
 treatment, total knee arthroplasty (TKA) is the operation that increases the quality of life
 for the patient. Pain management after total knee arthroplasty TKA is an important
 consideration to improve patient outcomes and reduce length of stay. Periarticular injections
 of the knee are one of the techniques used to reduce pain after surgery. Studies have shown
 that compared to other methods of pain relief, they are effective and safe. At present, no
 studies to compare between multimodal intraosseous femoral injection & multimodal
 intraosseous tibial injection in Simultaneous Bilateral TKA patients.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06243575
Non-Device Trial